The Psoriasis Association
This sponsor has funded 1 studies across 28 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 35860 | Planned | The PsoProtect Research Database (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) | No | No |
PAS by Risk Management Plan (RMP) requirement
The Psoriasis Association
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
The Psoriasis Association
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
The Psoriasis Association
28 Study countries specified are the following:
- Argentina
- Australia
- Austria
- Belgium
- Brazil
- Canada
- Chile
- Colombia
- France
- Germany
- India
- Iran, Islamic Republic of
- Italy
- Luxembourg
- Malaysia
- Mauritius
- Netherlands
- Norway
- Peru
- Philippines
- Poland
- Spain
- Sweden
- Thailand
- Türkiye
- United Arab Emirates
- United Kingdom
- United States